SeqOne Genomics

For this reason, we are committed to making this life changing technology available to as many people as possible. SeqOne Genomics is a startup based in Montpellier in the South of France, founded in 2017. Its flagship product, SeqOne | Platform is a cloud-based end-to-end solution that dramatically reduces the turnaround time and cost required to deliver accurate genetic analyses, for use in mainstream medicine. SeqOne is supported by the SATT AxLR and the Montpellier BIC incubator. SeqOne Platform is an in vitro diagnostic medical device, CE-IVD certified, designed to perform bioinformatics analysis of raw high-throughput sequencing data to help diagnosis. Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use. We are pleased to announce the appointment of Martin Dubuc as new Chief Executive Officer of SeqOne Genomics. We are passionate about creating bioinformatic solutions that target hard-to-detect variants such as MNVs, Alu elements and mid-sized deletions.